U.S. Electrical Stock News

Wondering if TG Therapeutics at around US$34.30 is pricing in too much hope or not enough future potential? This article breaks down what that current tag may actually reflect. The stock has been volatile, with a 1% decline over the last 7 days, an 8.9% gain over 30 days, a 17.1% gain year to date, but a 10.5% decline over the past year and a 16.5% decline over 5 years, all against a 60.4% gain over 3 years. Recent news coverage around TG Therapeutics has focused on its position within the...

The Hartford (NYSE:HIG) announced a new collaboration with the University of Connecticut focused on extreme heat research, energy innovation, and worker safety, including pilot programs and sustainability research fellowships. The Hartford also joined as a founding member of Extreme Weather + Work, a Health Action Alliance initiative to help employers support workers before, during, and after extreme weather events. For investors watching how insurers respond to climate related risks, these...

In April 2026, Roofr and Pilotbird each announced new integrations with Verisk’s Xactimate and ClaimSearch platforms, aiming to streamline property and casualty insurance claims workflows by automating roof measurements and embedding human-verified social media investigations directly into insurers’ existing systems. These collaborations highlight how Verisk’s data and technology are becoming more deeply embedded in day-to-day claims decisions, potentially increasing customer reliance on its...

Key business mix and where Ormat makes its money Ormat Technologies (ORA) draws most of its revenue from its Electricity segment, alongside smaller but meaningful contributions from Product and Energy Storage, giving you three distinct revenue streams to assess in one stock. Electricity is the largest contributor, with US$693.9m of revenue, followed by the Product segment at US$216.69m and Energy Storage at US$78.96m. Together, these segments support total revenue of US$989.54m and offer...

Regulatory spotlight on Omnicom Group and peers Omnicom Group (OMC) is in the spotlight as the U.S. Federal Trade Commission negotiates a potential settlement with several large advertising firms over alleged coordination of boycotts against certain media platforms. The talks could lead to changes in how Omnicom and its peers advise clients on allocating advertising budgets across platforms that host political content. This introduces an additional regulatory consideration for investors...

If you are wondering whether Parker-Hannifin's share price still offers value after a strong run, the starting point is understanding what the current market price is really implying. The stock recently closed at US$957.00, with a 7.1% return over the last 30 days, a 7.0% return year to date, and a 72.2% return over the past year, on top of a 210.2% return over 3 years and 225.6% over 5 years. Recent coverage has focused on Parker-Hannifin as a key name within the broader capital goods...

Knight-Swift Transportation Holdings (KNX) recently cut its first quarter 2026 earnings guidance, pointing to higher fuel costs, arbitration awards, deferred projects, VAT decisions, and severe winter weather as key pressures on profitability. See our latest analysis for Knight-Swift Transportation Holdings. Despite the weaker earnings guidance, investors have recently pushed Knight-Swift’s share price to US$64.33, with a 30-day share price return of 22.81% and a 1-year total shareholder...

Aon has recently expanded its Data Center Lifecycle Insurance Program by an additional US$1.00 billion to a total of US$3.50 billion, while extending coverage to existing data centers beyond their first year of operations. This move underlines Aon’s push to provide integrated insurance and risk solutions for large, mission-critical digital infrastructure as cloud and AI workloads grow more complex. We’ll now examine how this expanded data center risk program may influence Aon’s investment...

If you are wondering whether BJ's Wholesale Club Holdings is priced attractively or already reflects its strengths, it helps to start with how the current share price lines up against different valuation checks. The stock closed at US$92.24, with returns of a 1.5% decline over 7 days, a 4.4% decline over 30 days, a small 0.3% gain year to date, and a 22.1% decline over the last year, following a 19.0% return over 3 years and 112.9% over 5 years. Recent coverage has focused on BJ's position...

If you are wondering whether Domino's Pizza is starting to look attractively priced, this article explains what the current share price might be implying about its value. The stock last closed at US$369.00, with a 1.2% decline over 7 days, a 6.9% decline over 30 days, a 13.2% decline year to date and a 19.6% decline over 1 year. The 3 year return stands at 19.4% and the 5 year return at a 1.2% decline. Recent coverage has focused on how the share price performance contrasts with earlier...

In recent days, Barclays highlighted DoorDash’s early partnerships with sidewalk robots and delivery drones as part of a broader industry shift toward autonomous last‑mile logistics that could cut delivery costs to around US$1 per order. This focus on automation, alongside DoorDash’s public alignment with US “no tax on tips” policies that have saved Dashers hundreds of millions of dollars, underscores how technology and regulation are jointly reshaping its cost base and worker...

Leadership change puts BioCryst’s R&D focus in the spotlight BioCryst Pharmaceuticals (BCRX) recently named Sandeep M. Menon as Chief Research and Development Officer, putting fresh attention on how new leadership could shape the company’s rare disease pipeline and longer term growth plans. See our latest analysis for BioCryst Pharmaceuticals. The appointment of Dr. Menon comes at a time when BioCryst’s share price has a 90 day share price return of 42.9% and a 1 year total shareholder return...

With Yum China Holdings up 19.9% over the past year, many investors are asking a simple question: is the current share price of US$48.54 offering good value, or is most of the upside already reflected? The picture is mixed in the shorter term, with a 3.2% decline over the last 7 days and a 10.1% decline over the last 30 days, while year to date the stock is roughly flat at a 0.8% gain. It is still ahead over 3 years, and lower over 5 years, with returns of 19.1% and 11.5% declines...

CRA International (CRAI) is back in focus after recent share price swings. The stock has been roughly flat over the past year but has shown a negative move over the past 3 months. See our latest analysis for CRA International. Recent trading tells a mixed story, with a 4.1% 30 day share price return set against a 23.1% decline over 90 days, while the 5 year total shareholder return of 126.2% reflects much stronger long term performance. If CRA International’s recent swings have you thinking...

Spire (NYSE:SR) agreed to sell its natural gas storage assets in Wyoming and Oklahoma to I Squared Capital. The transaction shifts Spire's portfolio toward regulated natural gas utilities and supports funding for its recent Nashville acquisition. The move reflects a material change in business mix and risk profile that has not yet been widely discussed. Spire is primarily a regulated natural gas utility, and this agreement to sell Wyoming and Oklahoma storage assets tightens that focus. By...

Earlier this week, Gilead Sciences announced expanded collaborations with the U.S. State Department, PEPFAR, and The Global Fund to widen access to its twice-yearly injectable HIV prevention medicine, lenacapavir, targeting up to an additional 1 million people through 2028 in high-incidence, resource-limited regions. This move not only extends Gilead’s reach in global HIV prevention but also highlights how no-profit pricing and planned generic rollout could reshape its role in public health...

Over the last 7 days, the United States market has experienced a significant decline of 29%, contributing to an overall drop of 82% over the past year, though earnings are forecast to grow by 16% annually. In such volatile conditions, identifying stocks that are undervalued relative to their intrinsic value can present opportunities for investors seeking potential long-term gains.

In recent days, CoreWeave completed and expanded multiple private offerings of its 9.750% senior notes due 2031, raising an additional US$1.00 billion at a price of 102% on top of an earlier US$1.75 billion tranche, while also issuing US$3.50 billion of 1.75% convertible notes due 2032. Alongside these financings, new multi-year AI cloud agreements with Meta Platforms, Anthropic and a roughly US$6.00 billion commitment from Jane Street, plus Jane Street’s US$1.00 billion equity purchase, are...

If you are wondering whether Gap's share price still offers value after a strong run, or if most of the opportunity is already priced in, this article breaks down what the current market price might be implying about the company. Gap's stock has seen a 40.3% return over the last year and 209.3% over the last 3 years, while the most recent 7 day return of a 1.1% decline sits against a 9.4% gain over the last 30 days and a 3.5% return year to date. Recent headlines around Gap have focused on...

Western Midstream Partners triggered stock overview Western Midstream Partners (WES) has drawn fresh attention after recent trading, with the units closing at US$40.85. Investors are weighing this level against the partnership’s income profile and longer term return record. See our latest analysis for Western Midstream Partners. The latest move to US$40.85 comes after a modest 1 day share price return of 1.09%, set against a slightly weaker 30 day share price return of 1.47%. At the same...

Over the last 7 days, the United States market has experienced a significant drop of 29%, contributing to an overall decline of 82% over the past year. In light of these challenging conditions, identifying growth companies with substantial insider ownership can be particularly appealing as it often indicates confidence in future performance and alignment with shareholder interests.

Over the last 7 days, the United States market has experienced a significant downturn, dropping 29%, and is down 82% over the past year, though earnings are forecast to grow by 16% annually. In challenging market conditions like these, identifying stocks with strong financial fundamentals becomes crucial for investors seeking potential opportunities. Although "penny stocks" may seem like an outdated term, they continue to represent smaller or newer companies that can offer both affordability...

If you are wondering whether Fluor's current share price lines up with its underlying worth, this breakdown will help you connect the recent share performance with what the fundamentals may be implying. The stock recently closed at US$47.88, with returns of 7.2% over 30 days, 14.8% year to date and 41.0% over 1 year. This puts valuation questions front and center for many investors. Over longer periods, Fluor has recorded returns of 60.0% over 3 years and 122.9% over 5 years. This provides...

Earlier this month, Annexon, Inc. presented at the 25th Annual Needham Virtual Healthcare Conference, where CEO Douglas E. Love outlined the company’s upcoming clinical and regulatory milestones. A key takeaway was management’s description of 2026 as a “win year,” highlighting expected GBS regulatory filings, a Phase III geographic atrophy readout, and proof-of-concept data for ANX1502, all supported by a cash runway projected into the second half of 2027. We’ll now look at how this “win...